Physician profile
Michael Monahan
NPI 1114213428
$18,175.09
in general payments reported to CMS, 2019-2025
42 companies · $2,243 in 2025
The $2,243 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,683 · 2020: $2,082 · 2021: $2,184 · 2022: $3,835 · 2023: $3,523 · 2024: $2,624 · 2025: $2,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,382 · Education: $8.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,381.92 |
| Education | $8.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,709.28 | 2020-2024 | Axonics |
| Medtronic, INC. | $2,207.08 | 2021-2025 | Interstim |
| Medtronic USA, INC. | $1,318.07 | 2019-2020 | |
| Astellas Pharma US INC | $997.52 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $938.66 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $880.99 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $844.65 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $741.55 | 2020-2025 | |
| Coloplast Corp | $740.59 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $710.10 | 2023-2025 | Prolaris |
| Accord Healthcare, INC. | $635.97 | 2023-2025 | |
| Boston Scientific Corporation | $507.30 | 2019-2024 | Ams 700, Ams 700 Cxr Rte Kit |
| Antares Pharma, INC. | $499.57 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Procept Biorobotics Corporation | $477.21 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Janssen Biotech, INC. | $473.84 | 2019-2025 | Erleada, Akeega, Balversa |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $430.45 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Urogen Pharma, INC. | $402.95 | 2021-2025 | |
| Myovant Sciences INC. | $357.97 | 2021-2022 | |
| Teleflex LLC | $295.03 | 2023-2025 | Barrigel, Urolift |
| Abbvie INC. | $268.72 | 2019-2025 | |
| Urovant Sciences INC | $219.01 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $209.84 | 2019-2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $206.12 | 2020-2023 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $185.91 | 2022-2024 | Lynparza |
| Allergan, INC. | $162.73 | 2019-2022 | |
| Amgen INC. | $138.62 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $106.84 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $96.97 | 2022-2024 | Yonsa |
| Edwards Lifesciences Corporation | $85.96 | 2019 | |
| 180 Medical, INC. | $80.67 | 2020-2022 | |
| Halozyme INC | $64.79 | 2023 | |
| Laborie Medical Technologies Corp. | $29.14 | 2023-2024 | Urgent PC Neuromodulation System |
| Innovation Technologies INC | $19.94 | 2024 | Irrisept |
| Verity Pharmaceuticals INC. | $18.38 | 2025 | Tlando |
| Calyxo, INC. | $17.42 | 2025 | Cvac Aspiration System |
| Janssen Pharmaceuticals, INC | $17.20 | 2022 | |
| Blue Earth Diagnostics | $16.70 | 2021 | |
| Cook Medical LLC | $13.91 | 2023 | Fiber Dust |
| Acerus Pharmaceuticals Corporation | $13.65 | 2022 | |
| Rochester Medical Corporation | $12.36 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $11.13 | 2019 | |
| Clovis Oncology, INC. | $10.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Monahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.